Read more

Mepolizumab: First Global Approval.

Related ArticlesMepolizumab: First Global Approval.
Drugs. 2015 Nov 24;
Authors: Keating GM
Abstract
Mepolizumab (Nucala(®)) is a fully humanized monoclonal antibody against interleukin-5 (IL-5) that is be…

Read more

Idarucizumab: First Global Approval.

Idarucizumab: First Global Approval.
Drugs. 2015 Nov 17;
Authors: Burness CB
Abstract
Idarucizumab (Praxbind(®)) is a fully humanized, monoclonal antibody fragment developed by Boehringer Ingelheim as a sp…

Read more

Omarigliptin: First Global Approval.

Omarigliptin: First Global Approval.
Drugs. 2015 Oct 27;
Authors: Burness CB
Abstract
Omarigliptin [Marizev(®) (Japan)] is a small-molecule dipeptidyl peptidase-4 (DPP-4) inhibitor developed by Merck for t…